市場調査レポート：世界の非ステロイド性抗炎症性API市場（～2028年）：アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、その他

• 英文タイトル：Global Non-Steroidal Anti-Inflammatory API Market Insights, Forecast to 2028

Global Non-Steroidal Anti-Inflammatory API Market Insights, Forecast to 2028「世界の非ステロイド性抗炎症性API市場（～2028年）：アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、その他」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-02669
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、111ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：化学&材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、非ステロイド性抗炎症性APIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
非ステロイド性抗炎症性APIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
非ステロイド性抗炎症性APIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
非ステロイド性抗炎症性APIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの非ステロイド性抗炎症性APIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の非ステロイド性抗炎症性APIの売上および2028年までの予測に焦点を当てています。

非ステロイド性抗炎症性APIのグローバル主要企業には、Luan Pharmaceutical、Basf Company、Fengyuan Pharmaceutical、Xinhua Pharmaceutical、Changshu Huagang Pharmaceutical、Hebei Jiheng Group、Zhejiang Kangle Group、Hebei Jingye Medical Technology、Hunan Middle-south Pharmaceutical、Mallinckrodt Pharmaceuticals、IOL、Novacyl、Granules India Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

非ステロイド性抗炎症性API市場は、タイプとアプリケーションによって区分されます。世界の非ステロイド性抗炎症性API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、その他

【アプリケーション別セグメント】
医療用医薬品、科学研究

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 非ステロイド性抗炎症性API製品概要
- タイプ別市場（アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、その他）
- アプリケーション別市場（医療用医薬品、科学研究）
- 調査の目的
・エグゼクティブサマリー
- 世界の非ステロイド性抗炎症性API販売量予測2017-2028
- 世界の非ステロイド性抗炎症性API売上予測2017-2028
- 非ステロイド性抗炎症性APIの地域別販売量
- 非ステロイド性抗炎症性APIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別非ステロイド性抗炎症性API販売量
- 主要メーカー別非ステロイド性抗炎症性API売上
- 主要メーカー別非ステロイド性抗炎症性API価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、その他）
- 非ステロイド性抗炎症性APIのタイプ別販売量
- 非ステロイド性抗炎症性APIのタイプ別売上
- 非ステロイド性抗炎症性APIのタイプ別価格
・アプリケーション別市場規模（医療用医薬品、科学研究）
- 非ステロイド性抗炎症性APIのアプリケーション別販売量
- 非ステロイド性抗炎症性APIのアプリケーション別売上
- 非ステロイド性抗炎症性APIのアプリケーション別価格
・北米市場
- 北米の非ステロイド性抗炎症性API市場規模（タイプ別、アプリケーション別）
- 主要国別の非ステロイド性抗炎症性API市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの非ステロイド性抗炎症性API市場規模（タイプ別、アプリケーション別）
- 主要国別の非ステロイド性抗炎症性API市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の非ステロイド性抗炎症性API市場規模（タイプ別、アプリケーション別）
- 主要国別の非ステロイド性抗炎症性API市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の非ステロイド性抗炎症性API市場規模（タイプ別、アプリケーション別）
- 主要国別の非ステロイド性抗炎症性API市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの非ステロイド性抗炎症性API市場規模（タイプ別、アプリケーション別）
- 主要国別の非ステロイド性抗炎症性API市場規模（トルコ、サウジアラビア）
・企業情報
Luan Pharmaceutical、Basf Company、Fengyuan Pharmaceutical、Xinhua Pharmaceutical、Changshu Huagang Pharmaceutical、Hebei Jiheng Group、Zhejiang Kangle Group、Hebei Jingye Medical Technology、Hunan Middle-south Pharmaceutical、Mallinckrodt Pharmaceuticals、IOL、Novacyl、Granules India Limited
・産業チェーン及び販売チャネル分析
- 非ステロイド性抗炎症性APIの産業チェーン分析
- 非ステロイド性抗炎症性APIの原材料
- 非ステロイド性抗炎症性APIの生産プロセス
- 非ステロイド性抗炎症性APIの販売及びマーケティング
- 非ステロイド性抗炎症性APIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 非ステロイド性抗炎症性APIの産業動向
- 非ステロイド性抗炎症性APIのマーケットドライバー
- 非ステロイド性抗炎症性APIの課題
- 非ステロイド性抗炎症性APIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Non-Steroidal Anti-Inflammatory API Market
Due to the COVID-19 pandemic, the global Non-Steroidal Anti-Inflammatory API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Aspirin accounting for % of the Non-Steroidal Anti-Inflammatory API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Non-Steroidal Anti-Inflammatory API market size is valued at US$ million in 2021, while the US and Europe Non-Steroidal Anti-Inflammatory API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non-Steroidal Anti-Inflammatory API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Non-Steroidal Anti-Inflammatory API include Luan Pharmaceutical, Basf Company, Fengyuan Pharmaceutical, Xinhua Pharmaceutical, Changshu Huagang Pharmaceutical, Hebei Jiheng Group, Zhejiang Kangle Group, Hebei Jingye Medical Technology and Hunan Middle-south Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Non-Steroidal Anti-Inflammatory API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Non-Steroidal Anti-Inflammatory API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Non-Steroidal Anti-Inflammatory API Scope and Segment
Non-Steroidal Anti-Inflammatory API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapzin
Others
Segment by Application
Medical Pharmaceutical
Scientific Research
By Company
Luan Pharmaceutical
Basf Company
Fengyuan Pharmaceutical
Xinhua Pharmaceutical
Changshu Huagang Pharmaceutical
Hebei Jiheng Group
Zhejiang Kangle Group
Hebei Jingye Medical Technology
Hunan Middle-south Pharmaceutical
Mallinckrodt Pharmaceuticals
IOL
Novacyl
Granules India Limited
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Non-Steroidal Anti-Inflammatory API Product Introduction
1.2 Market by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Diclofenac
1.2.6 Oxapzin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Non-Steroidal Anti-Inflammatory API Production
2.1 Global Non-Steroidal Anti-Inflammatory API Production Capacity (2017-2028)
2.2 Global Non-Steroidal Anti-Inflammatory API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Non-Steroidal Anti-Inflammatory API Production by Region
2.3.1 Global Non-Steroidal Anti-Inflammatory API Historic Production by Region (2017-2022)
2.3.2 Global Non-Steroidal Anti-Inflammatory API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Non-Steroidal Anti-Inflammatory API Sales in Volume & Value Estimates and Forecasts
3.1 Global Non-Steroidal Anti-Inflammatory API Sales Estimates and Forecasts 2017-2028
3.2 Global Non-Steroidal Anti-Inflammatory API Revenue Estimates and Forecasts 2017-2028
3.3 Global Non-Steroidal Anti-Inflammatory API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Non-Steroidal Anti-Inflammatory API Sales by Region
3.4.1 Global Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2022)
3.4.2 Global Sales Non-Steroidal Anti-Inflammatory API by Region (2023-2028)
3.5 Global Non-Steroidal Anti-Inflammatory API Revenue by Region
3.5.1 Global Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2022)
3.5.2 Global Non-Steroidal Anti-Inflammatory API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Non-Steroidal Anti-Inflammatory API Production Capacity by Manufacturers
4.2 Global Non-Steroidal Anti-Inflammatory API Sales by Manufacturers
4.2.1 Global Non-Steroidal Anti-Inflammatory API Sales by Manufacturers (2017-2022)
4.2.2 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Steroidal Anti-Inflammatory API in 2021
4.3 Global Non-Steroidal Anti-Inflammatory API Revenue by Manufacturers
4.3.1 Global Non-Steroidal Anti-Inflammatory API Revenue by Manufacturers (2017-2022)
4.3.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory API Revenue in 2021
4.4 Global Non-Steroidal Anti-Inflammatory API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Non-Steroidal Anti-Inflammatory API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Non-Steroidal Anti-Inflammatory API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Non-Steroidal Anti-Inflammatory API Sales by Type
5.1.1 Global Non-Steroidal Anti-Inflammatory API Historical Sales by Type (2017-2022)
5.1.2 Global Non-Steroidal Anti-Inflammatory API Forecasted Sales by Type (2023-2028)
5.1.3 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2028)
5.2 Global Non-Steroidal Anti-Inflammatory API Revenue by Type
5.2.1 Global Non-Steroidal Anti-Inflammatory API Historical Revenue by Type (2017-2022)
5.2.2 Global Non-Steroidal Anti-Inflammatory API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2028)
5.3 Global Non-Steroidal Anti-Inflammatory API Price by Type
5.3.1 Global Non-Steroidal Anti-Inflammatory API Price by Type (2017-2022)
5.3.2 Global Non-Steroidal Anti-Inflammatory API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Non-Steroidal Anti-Inflammatory API Sales by Application
6.1.1 Global Non-Steroidal Anti-Inflammatory API Historical Sales by Application (2017-2022)
6.1.2 Global Non-Steroidal Anti-Inflammatory API Forecasted Sales by Application (2023-2028)
6.1.3 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2028)
6.2 Global Non-Steroidal Anti-Inflammatory API Revenue by Application
6.2.1 Global Non-Steroidal Anti-Inflammatory API Historical Revenue by Application (2017-2022)
6.2.2 Global Non-Steroidal Anti-Inflammatory API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application (2017-2028)
6.3 Global Non-Steroidal Anti-Inflammatory API Price by Application
6.3.1 Global Non-Steroidal Anti-Inflammatory API Price by Application (2017-2022)
6.3.2 Global Non-Steroidal Anti-Inflammatory API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Non-Steroidal Anti-Inflammatory API Market Size by Type
7.1.1 North America Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2028)
7.1.2 North America Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2028)
7.2 North America Non-Steroidal Anti-Inflammatory API Market Size by Application
7.2.1 North America Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2028)
7.2.2 North America Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2028)
7.3 North America Non-Steroidal Anti-Inflammatory API Sales by Country
7.3.1 North America Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2028)
7.3.2 North America Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Non-Steroidal Anti-Inflammatory API Market Size by Type
8.1.1 Europe Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2028)
8.1.2 Europe Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2028)
8.2 Europe Non-Steroidal Anti-Inflammatory API Market Size by Application
8.2.1 Europe Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2028)
8.2.2 Europe Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2028)
8.3 Europe Non-Steroidal Anti-Inflammatory API Sales by Country
8.3.1 Europe Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2028)
8.3.2 Europe Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Non-Steroidal Anti-Inflammatory API Market Size by Type
9.1.1 Asia Pacific Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2028)
9.1.2 Asia Pacific Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2028)
9.2 Asia Pacific Non-Steroidal Anti-Inflammatory API Market Size by Application
9.2.1 Asia Pacific Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2028)
9.2.2 Asia Pacific Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2028)
9.3 Asia Pacific Non-Steroidal Anti-Inflammatory API Sales by Region
9.3.1 Asia Pacific Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2028)
9.3.2 Asia Pacific Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Non-Steroidal Anti-Inflammatory API Market Size by Type
10.1.1 Latin America Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2028)
10.1.2 Latin America Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2028)
10.2 Latin America Non-Steroidal Anti-Inflammatory API Market Size by Application
10.2.1 Latin America Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2028)
10.2.2 Latin America Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2028)
10.3 Latin America Non-Steroidal Anti-Inflammatory API Sales by Country
10.3.1 Latin America Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2028)
10.3.2 Latin America Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Non-Steroidal Anti-Inflammatory API Market Size by Type
11.1.1 Middle East and Africa Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2028)
11.2 Middle East and Africa Non-Steroidal Anti-Inflammatory API Market Size by Application
11.2.1 Middle East and Africa Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2028)
11.3 Middle East and Africa Non-Steroidal Anti-Inflammatory API Sales by Country
11.3.1 Middle East and Africa Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Luan Pharmaceutical
12.1.1 Luan Pharmaceutical Corporation Information
12.1.2 Luan Pharmaceutical Overview
12.1.3 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Luan Pharmaceutical Recent Developments
12.2 Basf Company
12.2.1 Basf Company Corporation Information
12.2.2 Basf Company Overview
12.2.3 Basf Company Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Basf Company Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Basf Company Recent Developments
12.3 Fengyuan Pharmaceutical
12.3.1 Fengyuan Pharmaceutical Corporation Information
12.3.2 Fengyuan Pharmaceutical Overview
12.3.3 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Fengyuan Pharmaceutical Recent Developments
12.4 Xinhua Pharmaceutical
12.4.1 Xinhua Pharmaceutical Corporation Information
12.4.2 Xinhua Pharmaceutical Overview
12.4.3 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Xinhua Pharmaceutical Recent Developments
12.5 Changshu Huagang Pharmaceutical
12.5.1 Changshu Huagang Pharmaceutical Corporation Information
12.5.2 Changshu Huagang Pharmaceutical Overview
12.5.3 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Changshu Huagang Pharmaceutical Recent Developments
12.6 Hebei Jiheng Group
12.6.1 Hebei Jiheng Group Corporation Information
12.6.2 Hebei Jiheng Group Overview
12.6.3 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Hebei Jiheng Group Recent Developments
12.7 Zhejiang Kangle Group
12.7.1 Zhejiang Kangle Group Corporation Information
12.7.2 Zhejiang Kangle Group Overview
12.7.3 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Kangle Group Recent Developments
12.8 Hebei Jingye Medical Technology
12.8.1 Hebei Jingye Medical Technology Corporation Information
12.8.2 Hebei Jingye Medical Technology Overview
12.8.3 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hebei Jingye Medical Technology Recent Developments
12.9 Hunan Middle-south Pharmaceutical
12.9.1 Hunan Middle-south Pharmaceutical Corporation Information
12.9.2 Hunan Middle-south Pharmaceutical Overview
12.9.3 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hunan Middle-south Pharmaceutical Recent Developments
12.10 Mallinckrodt Pharmaceuticals
12.10.1 Mallinckrodt Pharmaceuticals Corporation Information
12.10.2 Mallinckrodt Pharmaceuticals Overview
12.10.3 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Mallinckrodt Pharmaceuticals Recent Developments
12.11 IOL
12.11.1 IOL Corporation Information
12.11.2 IOL Overview
12.11.3 IOL Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 IOL Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 IOL Recent Developments
12.12 Novacyl
12.12.1 Novacyl Corporation Information
12.12.2 Novacyl Overview
12.12.3 Novacyl Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Novacyl Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Novacyl Recent Developments
12.13 Granules India Limited
12.13.1 Granules India Limited Corporation Information
12.13.2 Granules India Limited Overview
12.13.3 Granules India Limited Non-Steroidal Anti-Inflammatory API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Granules India Limited Non-Steroidal Anti-Inflammatory API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Granules India Limited Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Non-Steroidal Anti-Inflammatory API Industry Chain Analysis
13.2 Non-Steroidal Anti-Inflammatory API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Non-Steroidal Anti-Inflammatory API Production Mode & Process
13.4 Non-Steroidal Anti-Inflammatory API Sales and Marketing
13.4.1 Non-Steroidal Anti-Inflammatory API Sales Channels
13.4.2 Non-Steroidal Anti-Inflammatory API Distributors
13.5 Non-Steroidal Anti-Inflammatory API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Non-Steroidal Anti-Inflammatory API Industry Trends
14.2 Non-Steroidal Anti-Inflammatory API Market Drivers
14.3 Non-Steroidal Anti-Inflammatory API Market Challenges
14.4 Non-Steroidal Anti-Inflammatory API Market Restraints
15 Key Finding in The Global Non-Steroidal Anti-Inflammatory API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer